Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity. 2009

Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
Department of Chemical Sciences, University of Camerino, Camerino, Italy. dario.giardina@unicam.it

Doxazosin analogues 1-3 and 1a were synthesized and investigated at alpha1-adrenoceptors and PC-3, DU-145, and LNCaP human prostate cancer cells. Compound 1 (cyclodoxazosin) was a potent alpha(1B)-adrenoceptor antagonist displaying antiproliferative activity higher than that of doxazosin in cancer cells in vitro and in vivo, respectively. Because of its antitumor efficacy at low concentrations, lower apoptotic activity in NHDF vs tumor cells, and antiangiogenetic effect, 1 showed a better therapeutic profile relative to doxazosin.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000317 Adrenergic alpha-Antagonists Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. Adrenergic alpha-Receptor Blockaders,alpha-Adrenergic Blocking Agents,alpha-Adrenergic Receptor Blockaders,alpha-Blockers, Adrenergic,Adrenergic alpha-Blockers,alpha-Adrenergic Antagonists,alpha-Adrenergic Blockers,Adrenergic alpha Antagonists,Adrenergic alpha Blockers,Adrenergic alpha Receptor Blockaders,Agents, alpha-Adrenergic Blocking,Antagonists, alpha-Adrenergic,Blockaders, Adrenergic alpha-Receptor,Blockaders, alpha-Adrenergic Receptor,Blockers, alpha-Adrenergic,Blocking Agents, alpha-Adrenergic,Receptor Blockaders, alpha-Adrenergic,alpha Adrenergic Antagonists,alpha Adrenergic Blockers,alpha Adrenergic Blocking Agents,alpha Adrenergic Receptor Blockaders,alpha Blockers, Adrenergic,alpha-Antagonists, Adrenergic,alpha-Receptor Blockaders, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016466 CHO Cells CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells. CHO Cell,Cell, CHO,Cells, CHO

Related Publications

Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
March 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
August 2000, Cancer research,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
January 2002, Cancer research,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
January 2002, Anticancer research,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
December 2009, Naunyn-Schmiedeberg's archives of pharmacology,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
January 1999, European urology,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
January 1999, European urology,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
April 2008, Zhonghua nan ke xue = National journal of andrology,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
October 2005, Journal of cardiovascular pharmacology,
Dario Giardinà, and Daniele Martarelli, and Gianni Sagratini, and Piero Angeli, and Dario Ballinari, and Ugo Gulini, and Carlo Melchiorre, and Elena Poggesi, and Pierluigi Pompei
June 1999, European journal of pharmacology,
Copied contents to your clipboard!